Nevro Corp
(NYSE:NVRO)
$
5.06
-0.26 (-4.89%)
Market Cap: 188.65 Mil
Enterprise Value: 166.94 Mil
PE Ratio: 0
PB Ratio: 0.69
GF Score: 42/100 Nevro Corp at Citi Healthcare Conference (Virtual) Transcript
Feb 24, 2022 / 05:30PM GMT
Release Date Price:
$70.96
(+10.14%)
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Thank you, and good afternoon, everybody. I'm Joanne Wuensch in case you don't know me, but I'm very pleased that this session we're going to be talking with Keith Grossman and Rod MacLeod from Nevro. Thank you very much, everybody, for joining us.
D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President
Thanks, Joanne, for having us.
Questions & Answers
Joanne Karen Wuensch
Citigroup Inc., Research Division - MD
Excellent. Keith, I was taking a look when I was preparing for this when you arrived and not on this earth, but at least at Nevro, and it's been almost exactly 3 years and talk about time going by quickly.
D. Keith Grossman
Nevro Corp. - Chairman of the Board, CEO & President
That's going by quickly, Joanne, I'm certain you weren't around when I arrived on this earth. So... I know that's not what you are talking about. It has gone by quickly. I would say that the
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot